Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging
Hansson, O. et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimer’s Dementia18, 2669–2686 (2022).
Google Scholar
Schindler, S. E. & Bateman, R. J. Combining blood-based biomarkers to predict risk for Alzheimer’s disease dementia. Nat. Aging1, 26–28. (2021).
Google Scholar
Simrén, J. et al. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s disease. Alzheimer’s & Dementia17, 1145–1156. (2021).
Google Scholar
Chatterjee, P. et al. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer’s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimer’s Dementia19, 1117–1134. (2023).
Google Scholar
Cullen, N. C. et al. Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat. Commun.12, 3555. (2021).
Google Scholar
Simrén, J. et al. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s disease. Alzheimer’s Dementia17, 1145–1156 (2021).
Google Scholar
Scheltens, P. et al. Alzheimer’s disease. Lancet388, 505–517. (2016).
Google Scholar
Chatterjee, P. et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Transl. Psychiatry11, 27. (2021).
Google Scholar
Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol.14, 577–589. (2018).
Google Scholar
Mattsson, N. et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer’s disease. EMBO Mol. Med.8, 1184–1196 (2016).
Google Scholar
Pais, M. V., Forlenza, O. V. & Diniz, B. S. Plasma biomarkers of Alzheimer’s disease: A review of available assays, recent developments, and implications for clinical practice. J. Alzheimers Dis. Rep.7, 355–380 (2023).
Google Scholar
Sperling, R. A. et al. The A4 study: stopping AD before symptoms begin?. Sci. Transl. Med.6, 228fs213 (2014).
Cummings, J. et al. Alzheimer’s disease drug development pipeline: 2023. Alzheimer’s & Dementia: Transl. Res. Clin. Interv.9, e12385. (2023).
Dantas, J. M. et al. Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer’s disease: A systematic review and meta-analysis. Neurol. Sci. (2023).
Google Scholar
van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med.388, 9–21. (2022).
Google Scholar
Brown, B. M., Peiffer, J. J. & Martins, R. N. Multiple effects of physical activity on molecular and cognitive signs of brain aging: Can exercise slow neurodegeneration and delay Alzheimer’s disease?. Mol. Psychiatry18, 864–874. (2013).
Google Scholar
Sujkowski, A., Hong, L., Wessells, R. J. & Todi, S. V. The protective role of exercise against age-related neurodegeneration. Ageing Res. Rev.74, 101543. (2022).
Google Scholar
Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet385, 2255–2263. (2015).
Google Scholar
Zhang, X. et al. Effect of physical activity on risk of Alzheimer’s disease: A systematic review and meta-analysis of twenty-nine prospective cohort studies. Ageing Res. Rev.92, 102127. (2023).
Google Scholar
Blondell, S. J., Hammersley-Mather, R. & Veerman, J. L. Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies. BMC Public Health14, 510. (2014).
Google Scholar
Sofi, F. et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J. Intern. Med.269, 107–117. (2011).
Google Scholar
Du, Z. et al. Physical activity can improve cognition in patients with Alzheimer’s disease: A systematic review and meta-analysis of randomized controlled trials. Clin. Interv. Aging13, 1593–1603. (2018).
Google Scholar
Jia, R.-X., Liang, J.-H., Xu, Y. & Wang, Y.-Q. Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: A meta-analysis. BMC Geriatrics19, 181. (2019).
Google Scholar
Forbes, D., Forbes, S. C., Blake, C. M., Thiessen, E. J. & Forbes, S. Exercise programs for people with dementia. Cochrane Database Syst. Rev.2015(50), 9–18 (2015).
Ciria, L. F. et al. An umbrella review of randomized control trials on the effects of physical exercise on cognition. Nat. Hum. Behav.7, 928–941. (2023).
Google Scholar
Brown, B. M., Peiffer, J. & Rainey-Smith, S. R. Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review. Ageing Res. Rev.50, 9–18. (2019).
Google Scholar
Maugeri, G. et al. Neuroprotective effects of physical activity via the adaptation of astrocytes. Cells10, 1542 (2021).
Google Scholar
Adlard, P. A., Perreau, V. M., Pop, V. & Cotman, C. W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci. : Off. J. Soc. Neurosci.25, 4217–4221 (2005).
Google Scholar
Liu, H. L., Zhao, G., Zhang, H. & Shi, L. D. Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav. Brain Res.256, 261–272. (2013).
Google Scholar
Brown, B. M. et al. Physical activity and amyloid-β plasma and brain levels: Results from the Australian imaging, biomarkers and lifestyle study of ageing. Mol. Psychiatry18, 875–881. (2013).
Google Scholar
Liang, K. Y. et al. Exercise and Alzheimer’s disease biomarkers in cognitively normal older adults. Ann. Neurol.68, 311–318 (2010).
Google Scholar
Raffin, J. et al. Associations between physical activity, blood-based biomarkers of neurodegeneration, and cognition in healthy older adults: The MAPT study. J. Gerontol.: Ser. A76, 1382–1390. (2021).
Google Scholar
Frederiksen, K. S., Gjerum, L., Waldemar, G. & Hasselbalch, S. G. Physical activity as a moderator of alzheimer pathology: A systematic review of observational studies. Curr. Alzheimer Res.16, 362–378. (2019).
Google Scholar
Rabin, J. S. et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol.76, 1203–1210 (2019).
Google Scholar
Desai, P. et al. Longitudinal association of total tau concentrations and physical activity with cognitive decline in a population sample. JAMA Netw. Open4, e2120398–e2120398. (2021).
Google Scholar
Desai, P. et al. Examination of neurofilament light chain serum concentrations, physical activity, and cognitive decline in older adults. JAMA Netw. Open5, e223596 (2022).
Google Scholar
Sallis, J. F. & Saelens, B. E. Assessment of physical activity by self-report: status, limitations, and future directions. Res. Q. Exerc. Sport71(Suppl 2), 1–14. (2000).
Google Scholar
Nilsson, J., Ekblom, M. & Lövdén, M. Associations of cardiorespiratory fitness and moderate-to-vigorous physical activity with latent cognitive abilities in older adults. Psychol. Sport Exerc.60, 102171. (2022).
Kukull, W. A. et al. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J. Clin. Epidemiol.47, 1061–1067. (1994).
Google Scholar
Nilsson, J. et al. Acute increases in brain-derived neurotrophic factor in plasma following physical exercise relates to subsequent learning in older adults. Sci. Rep.10, 1–15 (2020).
Tarassova, O., Ekblom, M. M., Moberg, M., Lövdén, M. & Nilsson, J. Peripheral BDNF response to physical and cognitive exercise and its association with cardiorespiratory fitness in healthy older adults. Front. Physiol.11, 1080 (2020).
Google Scholar
Verberk, I. M. W. et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer’s disease-related blood-based biomarkers: Results from the Standardization of Alzheimer’s Blood Biomarkers (SABB) working group. Alzheimer’s & dementia : J. Alzheimer’s Assoc.18, 1484–1497 (2022).
Google Scholar
Bezuidenhout, L., Thurston, C., Hagströmer, M. & Moulaee Conradsson, D. Validity of hip and ankle worn actigraph accelerometers for measuring steps as a function of gait speed during steady state walking and continuous turning. Sensors21, 3154 (2021).
Google Scholar
Sasaki, J. E., John, D. & Freedson, P. S. Validation and comparison of ActiGraph activity monitors. J. Sci. Med. Sport14, 411–416. (2011).
Google Scholar
Aguilar-Farías, N., Brown, W. J. & Peeters, G. M. ActiGraph GT3X+ cut-points for identifying sedentary behaviour in older adults in free-living environments. J. Sci. Med. Sport17, 293–299. (2014).
Google Scholar
Choi, L., Liu, Z., Matthews, C. E. & Buchowski, M. S. Validation of accelerometer wear and nonwear time classification algorithm. Med. Sci. Sports Exerc.43, 357–364 (2011).
Google Scholar
Choi, L., Ward, S. C., Schnelle, J. F. & Buchowski, M. S. Assessment of wear/nonwear time classification algorithms for triaxial accelerometer. Med. Sci. Sports Exerc.44, 2009–2016 (2012).
Google Scholar
Hallgren, K. A., McCabe, C. J., King, K. M. & Atkins, D. C. Beyond path diagrams: Enhancing applied structural equation modeling research through data visualization. Addict. Behav.94, 74–82 (2019).
Google Scholar
He, L. et al. Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults. Sci. Rep.11, 13394. (2021).
Google Scholar
Mielke, M. M. et al. Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. Neurology93, e252–e260 (2019).
Google Scholar
Kartau, M. et al. Neurofilament light level correlates with brain atrophy, and cognitive and motor performance. Front. Aging Neurosci.14, 939155. (2023).
Google Scholar
Nyberg, L. et al. Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer’s disease. Alzheimer’s & Dementia: Diagn. Assess. Dis. Monitor.12, e12050. (2020).
Leeuw, F.-E. et al. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The rotterdam scan study. J. Neurol. Neurosurg. Psychiatry70, 9–14. (2001).
Google Scholar
Bennett, I. J. & Madden, D. J. Disconnected aging: Cerebral white matter integrity and age-related differences in cognition. Neuroscience276, 187–205 (2014).
Google Scholar
Fjell, A. M., Sneve, M. H., Grydeland, H., Storsve, A. B. & Walhovd, K. B. The disconnected brain and executive function decline in aging. Cereb. Cortex27, 2303–2317. (2017).
Google Scholar
Friedman, N. P. & Miyake, A. Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex; J. Devoted Study Nerv. Syst. Behav.86, 186–204. (2017).
Molteni, R., Zheng, J. Q., Ying, Z., Gómez-Pinilla, F. & Twiss, J. L. Voluntary exercise increases axonal regeneration from sensory neurons. Proc. Natl. Acad. Sci. United States Am.101, 8473–8478 (2004).
Google Scholar
Markus, A., Patel, T. D. & Snider, W. D. Neurotrophic factors and axonal growth. Curr. Opin. Neurobio.12, 523–531. (2002).
Google Scholar
Lamb, S. E. et al. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: Randomised controlled trial. BMJ361, k1675. (2018).
Google Scholar
Wang, Y. et al. Objectively-measured movement behaviors, systemic low-grade inflammation, and plasma neurofilament light chain in older adults: A population-based study. Immun. Ageing20, 36. (2023).
Google Scholar
Noack, H., Lovden, M. & Schmiedek, F. On the validity and generality of transfer effects in cognitive training research. Psychol. Res.78, 773–789. (2014).
Google Scholar
link
:max_bytes(150000):strip_icc()/Health-GettyImages-1368554196-c285c1ac05034052b04149b68d38c2ae.jpg "13 Reasons You’re Not Losing Weight")
